Syngene International Ltd.

Syngene International Ltd.

Sales markets: Western Europe | Eastern Europe | Middle East | Asia | Australia | North America | Central/South America

About us

Syngene International Limited, (BSE code: 539268, NSE Id: SYNGENE, ISIN Id: INE398R01022) is India’s largest Contract Research Organization offering a suite of integrated, end-to-end discovery, development and manufacturing services for novel molecular entities across industrial sectors including pharmaceutical, biotechnology, agrochemicals, consumer health, animal health, cosmetic and nutrition companies.

Our service offerings in discovery and development cover multiple domains across small molecules, large molecules, antibody-drug conjugates (“ADC”) and oligonucleotides. Our integrated discovery and development platforms help organizations conduct discovery (from hit to candidate selection), development (including pre-clinical and clinical studies, analytical and bio-analytical evaluation, formulation development and stability studies) and pilot manufacturing (scale-up, pre-clinical and clinical supplies) with a distinctive economic advantage. We are also in the process of setting up a large scale manufacturing facility at Mangalore to strengthen our commercial manufacturing services.

Syngene brings together a state-of-the-art infrastructure spread across 1.3 Mn sq. ft. and a highly experienced team of about 3100 scientists, to help R&D focused organizations achieve better R&D efficiency and reduce development time. For more details, visit

Read more

Meet us at

18 apr 2018

CPhI Japan 2018

18 - 20 April 2018 Tokyo, Japan Visit us at stand L-24 Book a meeting See our Exhibitor Profile
24 apr 2018

CPhI North America 2018

24-26 April, 2018 Philadelphia, USA Visit us at stand 643 Book a meeting See our Exhibitor Profile
9 oct 2018

CPhI Worldwide 2018

9 - 11 October 2018 Madrid, Spain Visit us at stand 3C100 Book a meeting See our Exhibitor Profile

News about Syngene International Ltd.

Syngene International Announces Broadening of Research Collaboration with Amgen Inc.

9 Oct 2017

Syngene International Announces Broadening of Research Collaboration with Amgen Inc.

With the expansion, the floor space of Syngene Amgen Research & Development Center will double to 50,000 sq. ft. A team of up to 185 multi-disciplinary Syngene scientists will work in the areas of medicinal and process chemistry, biologics, bioprocess development, drug metabolism, pharmacokinetics, bioanalytical research and pharmaceutical development.

Read more



Antibody Drug Conjugates

Syngene’s Antibody Drug Conjugate (ADC) unit brings together an array of multidisciplinary capabilities in antibody generation, linker and payload chemistry, conjugation chemistry, in vitro and in vivo oncology in an integrated platform.

catalog | 2017-10-10

Syngene's bioinformatics services can be accessed either in a standalone manner or as part of an integrated project that could include discovery biology, chemistry, clinical development or safety assessment capabilities.

catalog | 2017-10-10
Biologics Development & Manufacturing

Syngene provides end to end development services in biologics manufacturing from cell line and process development through large scale production and supply of animal studies, clinical trial and commercial material. We offer one-stop shop support for the development of protein-based products for pharmaceutical and life sciences industries.

catalog | 2017-10-10
Chemical Development & Manufacturing

Syngene provides comprehensive Process Research &Development (PRD) and Current Good Manufacturing Practices (cGMP) manufacturing support to investigational and commercial programs. Our facilities have been inspected by regulatory authorities (Indian and International), certifying agencies, qualified persons, client QA and third party auditors. Our dedicated cGMP facility is certified by DCGI as well as by independent certifying agencies like TUV Nord.

catalog | 2017-10-10
Clinical Development

Syngene’s Clinical Development services group supports early phase through late phase clinical trials across a wide range of therapeutic areas.
Our Clinical Development Services includes clinical trial management, PK Analysis/Bioanalytical - small molecules and biologics, central lab, EDC services, Biometrics & Clinical data management, regulatory services, medical monitoring, pharmacovigilance and medical writing.

catalog | 2017-10-10
Corporate Booklet

Syngene is India’s largest contract research organization, which supports R&D programs from lead generation to clinical supplies. Our multi-disciplinary skills in integrated drug discovery and development include capabilities in medicinal chemistry, biology, in vivo pharmacology, toxicology, custom synthesis, process R&D, cGMP manufacturing, formulation and analytical development along with Clinical development services.

catalog | 2017-10-10
Discovery Biology

Syngene offer high quality, seamless and cost effective services in several areas including recombinant DNA engineering, cell line development, hybridoma technology, Next-Generation Sequencing, protein sciences (purification & crystallography), screening & assay biology, DMPK, in vivo pharmacology, toxicology and biologicals.

catalog | 2017-10-10
Discovery Chemistry

Syngene’s discovery chemistry services comprising of synthetic chemistry and medicinal chemistry have supported clients over the past two decades.Our state-of-the-art labs are equipped with various modern amenities which are well supported by a strong analytical team.

catalog | 2017-10-10
Formulation Development

Syngene provides services in formulation development for oral solid as well as liquid dosage forms including injectable formulations. We offer integrated services for new chemical entities, late phase product development and over-the-counter products with focus on quality, speed and cost-efficiency.

catalog | 2017-10-10
Oligonucleotide Services

Syngene’s Oligonucleotide capacity & services ranges from development to cGMP manufacturing of chemically synthesized high quality modified and non-modified custom Oligonucleotide (DNA/RNA), siRNA (single & double stranded, miRNA (modified and non-modified), Antisense, fast delivery of Oligonucleotides at various scales.

catalog | 2017-10-10
Safety Assessment/Toxicology Studies

Syngene’s experienced toxicology team is capable of identifying potential toxicity of a drug at an early stage of drug discovery helping our partners make fast and effective drug development decisions. We can assess mechanism-based toxicity and critical target organ toxicity at an early stage to provide a go-no-go decision point for the sponsors.

catalog | 2017-10-10
Stability Studies

Syngene offers analytical services for both small and large molecules for discovery and development processes across pharmaceuticals, fine chemicals, agro chemicals and other products using a variety of spectroscopic, chromatographic and physiochemical techniques.

catalog | 2017-10-10
Viral Testing

Syngene provides viral testing and clearance services that caters to clients need for fulfilling the viral safety for their biologics programs. State-of-the-art BSL-2 laboratory at the viral testing facility has GMP compliant systems and assays to ensure that regulatory expectations are met for product filing and licensing.

catalog | 2017-10-10